Fans attending World Cup at risk of ‘Camel Flu’, warn WHO experts
WHO-backed experts fear 'camel flu' could spread at this year's World Cup and cautions fans.
Health
Medical
Uncategorized
Drugs
Health
Medical
`Immunologic memory’ behind HIV inflammation: Study
Patients living with HIV are at an increased risk of developing chronic inflammation due to “immunologic memory,” according to a study
Drugs
Health
Medical
WHO sets up team to hunt down ‘Disease X’
The WHO is preparing for an unknown “Disease X” epidemic by convening more than 300 global scientists to draw evidence from more than 25 virus families and bacteria.
Drugs
Pharma
WHO wants pharma companies to disclose govt deals during world health emergencies
WHO drafts an agreement for pharma companies to disclose contract terms for emergency vaccines
Climate
Health
Medical
Pharma
G20 nations receive $136 million in debt daily as 828 million people face hunger: Oxfam
At a time when 828 million people are facing hunger, the G20 nations are receiving $136 million every day in debt payments from the world's poorest countries, according to Oxfam International calculations based on the World Bank International
Drugs
Health
Pharma
Global vaccine market remains ‘highly concentrated’
Global vaccine distribution has been inequitable, and vaccines that have been prioritised by the WHO does not see the light of the day, due to their limited profit potential.
Climate
Health
Diseases, health emergencies batter Horn of Africa: WHO
HQ Team November 4, 2022: Disease outbreaks and climate-related health emergencies have reached their highest-ever level this century in the Horn of Africa, according to the WHO. The outbreaks have deepened a health crisis in a region where
Health
India vaccinated 2.2 billion people, XBB new main variant
HQ Team October 31, 2022: About 2.20 billion people across the board have been administered Covid-19 vaccines in India, according to the government. More than 40 million teens aged 12-14 years have taken the first dose of the vaccine since
Drugs
Pharma
EMA cracks the whip on JAK inhibitors for inflammatory disorders
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to treat chronic inflammatory disorders.